EconPapers    
Economics at your fingertips  
 

Native-state proteomics of Parvalbumin interneurons identifies unique molecular signatures and vulnerabilities to early Alzheimer’s pathology

Prateek Kumar, Annie M. Goettemoeller, Claudia Espinosa-Garcia, Brendan R. Tobin, Ali Tfaily, Ruth S. Nelson, Aditya Natu, Eric B. Dammer, Juliet V. Santiago, Sneha Malepati, Lihong Cheng, Hailian Xiao, Duc D. Duong, Nicholas T. Seyfried, Levi B. Wood, Matthew J. M. Rowan (mjrowan@emory.edu) and Srikant Rangaraju (srikant.rangaraju@yale.edu)
Additional contact information
Prateek Kumar: Emory University School of Medicine
Annie M. Goettemoeller: Emory University School of Medicine
Claudia Espinosa-Garcia: Emory University School of Medicine
Brendan R. Tobin: Georgia Institute of Technology
Ali Tfaily: Yale University School of Medicine
Ruth S. Nelson: Yale University School of Medicine
Aditya Natu: Emory University School of Medicine
Eric B. Dammer: Emory University School of Medicine
Juliet V. Santiago: Emory University School of Medicine
Sneha Malepati: Emory University School of Medicine
Lihong Cheng: Emory University School of Medicine
Hailian Xiao: Emory University School of Medicine
Duc D. Duong: Emory University School of Medicine
Nicholas T. Seyfried: Emory University School of Medicine
Levi B. Wood: Georgia Institute of Technology
Matthew J. M. Rowan: Emory University School of Medicine
Srikant Rangaraju: Emory University School of Medicine

Nature Communications, 2024, vol. 15, issue 1, 1-26

Abstract: Abstract Dysfunction in fast-spiking parvalbumin interneurons (PV-INs) may represent an early pathophysiological perturbation in Alzheimer’s Disease (AD). Defining early proteomic alterations in PV-INs can provide key biological and translationally-relevant insights. We used cell-type-specific in-vivo biotinylation of proteins (CIBOP) coupled with mass spectrometry to obtain native-state PV-IN proteomes. PV-IN proteomic signatures include high metabolic and translational activity, with over-representation of AD-risk and cognitive resilience-related proteins. In bulk proteomes, PV-IN proteins were associated with cognitive decline in humans, and with progressive neuropathology in humans and the 5xFAD mouse model of Aβ pathology. PV-IN CIBOP in early stages of Aβ pathology revealed signatures of increased mitochondria and metabolism, synaptic and cytoskeletal disruption and decreased mTOR signaling, not apparent in whole-brain proteomes. Furthermore, we demonstrated pre-synaptic defects in PV-to-excitatory neurotransmission, validating our proteomic findings. Overall, in this study we present native-state proteomes of PV-INs, revealing molecular insights into their unique roles in cognitive resiliency and AD pathogenesis.

Date: 2024
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-024-47028-7 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-47028-7

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-024-47028-7

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla (sonal.shukla@springer.com) and Springer Nature Abstracting and Indexing (indexing@springernature.com).

 
Page updated 2024-12-28
Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-47028-7